摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Acetic acid 2-chloro-6-chlorocarbonyl-phenyl ester | 780771-73-5

中文名称
——
中文别名
——
英文名称
Acetic acid 2-chloro-6-chlorocarbonyl-phenyl ester
英文别名
(2-Carbonochloridoyl-6-chlorophenyl) acetate
Acetic acid 2-chloro-6-chlorocarbonyl-phenyl ester化学式
CAS
780771-73-5
化学式
C9H6Cl2O3
mdl
——
分子量
233.051
InChiKey
AGERRJIKBRGIJT-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    318.6±32.0 °C(Predicted)
  • 密度:
    1.408±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.8
  • 重原子数:
    14
  • 可旋转键数:
    3
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.11
  • 拓扑面积:
    43.4
  • 氢给体数:
    0
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    Acetic acid 2-chloro-6-chlorocarbonyl-phenyl esterammonium hydroxide 作用下, 以 四氢呋喃N,N-二甲基乙酰胺 为溶剂, 反应 17.0h, 生成 N-(4-Carbamimidoyl-phenyl)-3-chloro-2-hydroxy-benzamide
    参考文献:
    名称:
    4-Aminoarylguanidine and 4-aminobenzamidine derivatives as potent and selective urokinase-type plasminogen activator inhibitors
    摘要:
    The structure-based design of potent and selective urokinase-type plasminogen activator (uPA) inhibitors with 4-aminoarylamidine or 4-aminoarylguanidine S1 binding groups, is described. (C) 2002 Elsevier Science Ltd. All rights reserved.
    DOI:
    10.1016/s0960-894x(02)00312-8
  • 作为产物:
    描述:
    参考文献:
    名称:
    4-Aminoarylguanidine and 4-aminobenzamidine derivatives as potent and selective urokinase-type plasminogen activator inhibitors
    摘要:
    The structure-based design of potent and selective urokinase-type plasminogen activator (uPA) inhibitors with 4-aminoarylamidine or 4-aminoarylguanidine S1 binding groups, is described. (C) 2002 Elsevier Science Ltd. All rights reserved.
    DOI:
    10.1016/s0960-894x(02)00312-8
点击查看最新优质反应信息

文献信息

  • Design, Synthesis and Activity Evaluation of N-(pyridin-4-yl) Salicylamides as Antimycobacterial Agents
    作者:He Dian、De-Bin Zhou、Jian-Ping Mou、Zhu-Qing Yang、Jia Zhong、Xiao-Quan Ding、Chong Li、Xiao-Hong Wang、Jian-Gang Zhang
    DOI:10.14233/ajchem.2014.16594
    日期:——
    A series of N-(pyridin-4-yl) salicylamides derivatives were prepared through acylation of the corresponding acetylsalicyloyl chlorides with substituted 4-amino-pyridines. These compounds were evaluated in vitro for antimycobacterial activities against Mycobacterium tuberculosis (TB) and Mycobacterium avium (A) by the minimum inhibitory concentrations (MIC) values. Eight of the compounds exhibited lower MIC against A than the one of isoniazide. Meanwhile, four of the compounds exhibited good anti-TB activity compared to isoniazide. Antimycobacterial activities of N-(pyridin-4-yl) salicylamides were influenced by the balance between hydrophobicity and electron withdrawing substituent effects on the phenyl and pyridine ring. These studies show that the compounds might serve as prospective wide-spectrum antimycobacterial substances.
    一系列N-(吡啶-4-基)酰胺生物通过相应的乙酰水杨酰氯与取代的4-氨基吡啶的酰化反应制备而成。这些化合物通过最低抑制浓度(MIC)值在体外评估了对结核分枝杆菌(TB)和鸟分枝杆菌(A)的抗分枝杆菌活性。其中八种化合物的MIC值对A型菌低于异烟,同时有四种化合物表现出较异烟更强的抗TB活性。N-(吡啶-4-基)酰胺的抗分枝杆菌活性受到环和吡啶环上的疏性和电子吸引取代基效应之间平衡的影响。这些研究表明,这些化合物可能作为有前景的广谱抗分枝杆菌药物。
  • Thiazolides as Novel Antiviral Agents. 1. Inhibition of Hepatitis B Virus Replication
    作者:Andrew V. Stachulski、Chandrakala Pidathala、Eleanor C. Row、Raman Sharma、Neil G. Berry、Mazhar Iqbal、Joanne Bentley、Sarah A. Allman、Geoffrey Edwards、Alison Helm、Jennifer Hellier、Brent E. Korba、J. Edward Semple、Jean-Francois Rossignol
    DOI:10.1021/jm200153p
    日期:2011.6.23
    activity against HBV; by contrast, some related salicyloylanilides show a narrower spectrum of activity. The ADME properties of 3 are similar to 1; viz., the O-acetate is an effective prodrug, and the O-aryl glucuronide is a major metabolite. The QSAR study shows a good correlation of observed EC(90) for intracellular virions with thiazolide structural parameters. Finally we discuss the mechanism of action
    我们报告了多种噻唑烷 [即 2-羟基芳酰基-N-(噻唑-2-基)酰胺] 对抗乙型肝炎病毒复制的合成和活性,并对我们的结果进行了 QSAR 分析。原型噻唑硝唑尼特 [2-羟基甲酰基-N-(5-硝基噻唑-2-基)酰胺NTZ] 1 是一种广谱抗感染剂,可有效对抗厌细菌、病毒和寄生虫。相比之下,2-羟基甲酰-N-(5-氯噻唑-2-基)酰胺 3 是一种新型、有效、选择性的乙型肝炎复制抑制剂 (EC(50) = 0.33 μm),但对厌菌无活性。几种 4'- 和 5'-取代的噻唑化物对 HBV 显示出良好的活性;相比之下,一些相关的水杨酰苯胺的活性范围更窄。3 的 ADME 属性与 1 类似;即,O-乙酸是一种有效的前药,O-芳基葡糖苷酸是主要代谢物。QSAR 研究显示观察到的 EC(90) 与噻唑啉结构参数的细胞内病毒粒子具有良好的相关性。最后,我们讨论了与当前结果相关的噻唑化物的作用机制。
  • Catechol based inhibitors of 15-lipoxygenase
    作者:Bradley D. Tait、Richard D. Dyer、Bruce J. Auerbach、Dirk Bornemeier、Linda Guilds-Zamarka、Maritza Oxender、Bruce D. Roth、Bharat K. Trivedi、Joseph A. Cornicelli
    DOI:10.1016/0960-894x(95)00565-b
    日期:1996.1
    A potent 15-lipoxygenase (15-LO) inhibitor, compound 6, was identified by mass screening the Parke-Davis compound portfolio. The active moiety of compound 6 was determined to be the catechol functionality. Additional analogs were prepared and analyzed for inhibitory activity against 5-, 12-, and 15-lipoxygenase.
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫